Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Merck & Co. discloses IRAK-4 inhibitors

Sep. 26, 2016

Aurigene Discovery Technologies patents PD-1 signaling inhibitors

Sep. 26, 2016

GlaxoSmithKline prepares and tests bromodomain-containing protein inhibitors

Sep. 23, 2016

Dana-Farber Cancer Institute reports MELK inhibitors

Sep. 23, 2016

Alpharmagen patents nicotinic acetylcholine alpha7 receptor positive allosteric modulators

Sep. 23, 2016

Pharmakea describes LOXL2 inhibitors

Sep. 23, 2016

Astellas Pharma and Kotobuki Pharmaceutical patent agents for nocturia

Sep. 23, 2016

Melinta Therapeutics presents antibacterials

Sep. 22, 2016

Medshine Discovery develops CDK4/cyclin D1 and CDK6/cyclin D1 inhibitors

Sep. 22, 2016

Nanjing Sanhome Pharmaceutical describes PI3Kdelta inhibitors

Sep. 22, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...